Evidence map›Paper›PMID 41878464›Full record

ArticleGE Portuguese journal of gastroenterology

Managing Advanced Fibrolamellar Carcinoma at Stage IV: A Case Report.

Ivánia Furtado, Nuno Gião, Martim Urbano, João Boavida Ferreira

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in GE Portuguese journal of gastroenterology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ivánia FurtadoMedical Oncology Department, Hospital de Santo António dos Capuchos, Unidade Local de Saúde de São José, Lisbon, Portugal.
Nuno GiãoPathology Department, Hospital Curry Cabral, Unidade Local de Saúde de São José, Lisbon, Portugal.
Martim UrbanoRadiology Department, Unidade Local de Saúde de São José, Lisbon, Portugal.
João Boavida FerreiraMedical Oncology Department, Hospital de Santo António dos Capuchos, Unidade Local de Saúde de São José, Lisbon, Portugal.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Fibrolamellar carcinoma (FLC) is a rare primary liver malignancy that predominantly affects young individuals without underlying liver disease, distinguishing it from typical hepatocellular carcinoma. It is characterized by the Case Presentation: We report a case of a 29-year-old woman diagnosed with metastatic FLC who was treated with 6 cycles of gemcitabine + oxaliplatin, achieving stable disease for nearly 1 year. However, she subsequently experienced disease progression and rapidly declined, preventing the initiation of further systemic therapy. Discussion/Conclusion: This case highlights the limitations of current systemic therapies and the urgent need for novel targeted treatments. Further research is essential to improve outcomes for patients with metastatic FLC.

Indexed as

Fibrolamellar carcinomaGemcitabineHepatocellular carcinomaNeoplasm metastasisOxaliplatin

Identifiers

PMID41878464
PMCPMC13008403

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.